Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Neuravi Limited

Clinical trials sponsored by Neuravi Limited, explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

A medical device company focused on neurovascular therapies, acquired by Johnson & Johnson.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1

New catheter aims to clear stroke clots faster

Disease control Recruiting now

This study tests a new device called the Adaptive Tip Catheter for removing blood clots in people having a severe stroke. About 74 adults will receive the catheter procedure within 24 hours of stroke symptoms. The goal is to see if the device can restore blood flow in the brain w…

Phase: NA • Sponsor: Neuravi Limited • Aim: Disease control

Last updated Aug 02, 2026 00:00 UTC